参附注射液调控lncRNA ZFAS1介导线粒体自噬改善脓毒症心功能障碍的作用机制OA
Mechanism of Shenfu Injection in Alleviating Septic Cardiac Dysfunction by Regulating lncRNA ZFAS1-Mediated Mitophagy
目的 探讨参附注射液调控长链非编码 RNA(lncRNA)锌指结构反义转录本 1(ZFAS1)介导线粒体自噬改善脓毒症心功能障碍的作用机制.方法 将 70 只雄性 C57BL/6J 小鼠随机分为空白组、模型组、参附注射液(SFI)组(10 mL·kg-1)、SFI+ZFAS1 过表达载体(pcDNA-ZFAS1)组、SFI+空载体(pcDNA)组,其中空白组 10 只,其余每组各 15 只.小鼠连续给药 7 d 后,采用腹腔注射脂多糖(LPS)构建脓毒症心功能障碍小鼠模型.造模12 h 后采用超声心动图评估小鼠心脏功能[左室射血分数(LVEF)、左室短轴缩短率(LVFS)、舒张末期左室内径(LVEDD)、收缩末期左室内径(LVESD)];ELISA法检测血清肿瘤坏死因子α(TNF-α)、白细胞介素(IL)-6、IL-1β水平;HE 染色法观察心肌组织病理变化;透射电镜观察心肌组织线粒体超微结构改变;RT-qPCR 法检测心肌组织 lncRNA ZFAS1、自噬效应蛋白(Beclin-1)、微管相关蛋白 1 轻链 3(LC3)、PTEN 诱导假定激酶 1(PINK1)、E3 泛素蛋白连接酶(Parkin)mRNA 表达水平;Western Blot 法检测心肌组织 PINK1、Parkin、LC3Ⅱ/LC3Ⅰ及 Beclin-1 蛋白表达水平.结果 (1)与空白组比较,模型组小鼠心肌细胞部分坏死、结构紊乱,细胞质空泡化,存在大量炎性浸润;线粒体结构紊乱、肿胀,嵴消失并出现液泡,自噬溶酶体减少.与模型组比较,SFI 组与 SFI+pcDNA 组小鼠心肌细胞坏死减少,肌纤维排列较为规整,炎性浸润减少,细胞空泡变性现象明显减少;线粒体结构较完整,排列较整齐,多数线粒体嵴结构清晰,并可见较多自噬溶酶体.与 SFI+pcDNA 组比较,SFI+pcDNA-ZFAS1 组小鼠出现明显的心肌细胞及线粒体损伤,自噬溶酶体减少.(2)与空白组比较,模型组小鼠心脏 LVEF、LVFS 水平降低(P<0.01),LVEDD、LVESD 及血清 TNF-α、IL-6、IL-1β 水平升高(P<0.05,P<0.01).与模型组比较,SFI 组与 SFI+pcDNA 组小鼠 LVEF、LVFS 水平升高(P<0.01),LVEDD、LVESD 及血清 TNF-α、IL-6、IL-1β 水平降低(P<0.05,P<0.01).与 SFI+pcDNA 组比较,SFI+pc DNA-ZFAS1 组小鼠 LVEF、LVFS 水平降低(P<0.01),LVEDD、LVESD 及血清 TNF-α、IL-6、IL-1β 水平升高(P<0.05,P<0.01).(3)与空白组比较,模型组小鼠心肌组织 lncRNA ZFAS1 mRNA 表达水平升高(P<0.01),PINK1、Parkin、LC3、Beclin-1 mRNA 及 PINK1、Parkin、Beclin-1、LC3Ⅱ/LC3Ⅰ蛋白表达水平显著降低(P<0.01).与模型组比较,SFI 组与 SFI+pcDNA 组小鼠心肌组织 lncRNA ZFAS1 mRNA 表达水平降低(P<0.01),PINK1、Parkin、LC3、Beclin-1 mRNA 及 PINK1、Parkin、Beclin-1、LC3Ⅱ/LC3Ⅰ蛋白表达水平明显升高(P<0.05,P<0.01).与 SFI+pcDNA 组比较,SFI+pcDNA-ZFAS1 组小鼠心肌组织 lncRNA ZFAS1 mRNA 表达升高(P<0.01),PINK1、Parkin、LC3、Beclin-1 mRNA 及 PINK1、Parkin、Beclin-1、LC3Ⅱ/LC3Ⅰ蛋白表达水平降低(P<0.05,P<0.01).结论 参附注射液可能通过降低 lncRNA ZFAS1 表达,促进心肌细胞线粒体自噬,从而改善小鼠脓毒症心功能障碍.
Objective To investigate the mechanism of Shenfu Injection(SFI)in alleviating septic cardiac dysfunction by regulating long non-coding RNA(lncRNA)zinc finger antisense transcript 1(ZFAS1)-mediated mitophagy.Methods Seventy male C57BL/6J mice were randomly divided into a blank group,a model group,a Shenfu Injection(SFI)group(10 mL·kg-1),an SFI+ZFAS1 overexpression vector(pcDNA-ZFAS1)group,and an SFI+empty vector(pcDNA)group.The blank group contained 10 mice,and each of the remaining groups had 15 mice.After 7 consecutive days of administration,the mouse model of septic cardiac dysfunction was established by intraperitoneal injection of LPS.At 12 hours after modeling,cardiac function was evaluated by echocardiography[left ventricular ejection fraction(LVEF),left ventricular fractional shortening(LVFS),left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD)].Serum levels of tumor necrosis factor-α(TNF-α),interleukin(IL)-6,and IL-1β were detected by ELISA.Pathological changes of myocardial tissue were observed by HE staining.Ultrastructural changes of myocardial mitochondria were observed by transmission electron microscopy.The mRNA expression levels of lncRNA ZFAS1,Beclin-1,microtubule-associated protein 1 light chain 3(LC3),PTEN-induced putative kinase 1(PINK1),and E3 ubiquitin-protein ligase Parkin in myocardial tissue were detected by RT-qPCR.The protein expression levels of PINK1,Parkin,LC3 Ⅱ/LC3 Ⅰ,and Beclin-1 were detected by Western blotting.Results(1)Compared with the blank group,the model group showed partial myocardial cell necrosis,structural disorder,cytoplasmic vacuolation,and extensive inflammatory infiltration;mitochondria were structurally disordered and swollen,with disappeared cristae and vacuole formation.Compared with the model group,the SFI group and SFI+pcDNA group showed reduced myocardial cell necrosis,more regular arrangement of muscle fibers,decreased inflammatory infiltration,and significantly reduced cytoplasmic vacuolation;mitochondria were relatively intact and orderly arranged,with clear cristae in most mitochondria and abundant autophagolysosomes.Compared with the SFI+pcDNA group,the SFI+pcDNA-ZFAS1 group showed obvious myocardial cell and mitochondrial damage,with reduced autophagy.(2)Compared with the blank group,the model group showed decreased LVEF and LVFS(P<0.01),and increased LVEDD,LVESD,and serum levels of TNF-α,IL-6,and IL-1β(P<0.05,P<0.01).Compared with the model group,the SFI group and SFI+pcDNA group showed increased LVEF and LVFS(P<0.01),and decreased LVEDD,LVESD,and serum levels of TNF-α,IL-6,and IL-1β(P<0.05,P<0.01).Compared with the SFI+pcDNA group,the SFI+pcDNA-ZFAS1 group showed decreased LVEF and LVFS(P<0.01),and increased LVEDD,LVESD,and serum levels of TNF-α,IL-6,and IL-1β(P<0.05,P<0.01).(3)Compared with the blank group,the model group showed increased lncRNA ZFAS1 mRNA expression(P<0.01)and significantly decreased PINK1,Parkin,LC3,and Beclin-1 mRNA and PINK1,Parkin,Beclin-1,LC3Ⅱ/LC3Ⅰ,and protein expression(P<0.01)in myocardial tissue.Compared with the model group,the SFI group and SFI+pcDNA group showed decreased lncRNA ZFAS1 mRNA expression(P<0.01)and significantly increased PINK1,Parkin,LC3,Beclin-1 mRNA and protein expression of PINK1,Parkin,LC3 Ⅱ/LC3 Ⅰ,and Beclin-1(P<0.05,P<0.01).Compared with the SFI+pcDNA group,the SFI+pcDNA-ZFAS1 group showed increased lncRNA ZFAS1 mRNA expression(P<0.01),while the mRNA expression of PINK1,Parkin,LC3,Beclin-1,as well as the protein expression levels of PINK1,Parkin,Beclin-1 and LC3Ⅱ/LC3Ⅰ were significantly decreased(P<0.05,P<0.01).Conclusion Shenfu Injection may improve septic cardiac dysfunction in mice by downregulating lncRNA ZFAS1 expression and promoting cardiomyocyte mitophagy.
李莹鸿;钟淑婷;麦群香;孔政辉;刘育伟;李韬;靳利利
广东省第二中医院/广东省中医药工程技术研究院/广东省中医药研究开发重点实验室,广东 广州 510095||广州中医药大学第五临床医学院,广东 广州 510095广州中医药大学第五临床医学院,广东 广州 510095广州中医药大学第五临床医学院,广东 广州 510095广州中医药大学第五临床医学院,广东 广州 510095广州中医药大学第五临床医学院,广东 广州 510095广东省第二中医院/广东省中医药工程技术研究院/广东省中医药研究开发重点实验室,广东 广州 510095||广州中医药大学第五临床医学院,广东 广州 510095广东省第二中医院/广东省中医药工程技术研究院/广东省中医药研究开发重点实验室,广东 广州 510095||广州中医药大学第五临床医学院,广东 广州 510095
医药卫生
脓毒症心功能障碍参附注射液长链非编码RNAZFAS1线粒体自噬小鼠
septic cardiac dysfunctionShenfu Injectionlong non-coding RNAZFAS1mitophagymice
《中药新药与临床药理》 2026 (9)
1665-1674,10
广东省自然科学基金项目(2020A1515010588)广东省中医药局科研项目(20261025)广东省第二中医院科研创新基金资助项目(SEZYY2023A11).
评论